Laddar...
Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all
The application of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) has revolutionized the treatment of acute promyelocytic leukemia (APL). More than 80–90% of patients are expected to be cured with a combination of ATRA, ATO and/or chemotherapy. In this review, we focus on the remaining ob...
Sparad:
| I publikationen: | Leuk Lymphoma |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7479633/ https://ncbi.nlm.nih.gov/pubmed/31842650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2019.1613540 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|